Kudu Onepager

Kudu
 Medical Technologies
Reducing Procedures, Enhancing Lives
Revolutionizing medical implant charging through ultrasound
In-Vivo Trials: Calling All Implants Manufacturers
Join us for our upcoming in-vivo trials in March 2025 at Beth Israel Deaconess Hospital in Boston.
We will power up implants in pigs using our unique ultrasound charging device.
Witness firsthand how we achieve minimal device alterations for seamless recharging.
For more information, please contact Yuval at yuval@kudumed.com or call +972 542515698.
The Problem
Battery Replacement Surgeries
Globally, $60 billion is spent each year on surgeries to replace batteries in medical implants. This not only causes significant patient discomfort due to the frequency of surgeries but also introduces the risk of medical complications with each procedure.
Economic Impact
The worldwide expense of battery replacement surgeries reaches a staggering $60 billion annually.
Patient Discomfort
Frequent surgeries for battery replacements significantly diminish patients' quality of life. 
Surgical Complications
Each battery replacement surgery carries a risk of severe medical complications, posing a continuous threat to patient health.
💲 Hidden Costs
The global market for battery-powered medical implants is valued at $20 billion, including cardiovascular devices like pacemakers, ICDs, and CRT implants, and neurostimulator implants, each segment approximately $5 billion. However, the true cost extends to $60 billion annually in replacement expenses, as per insurance data. Kudu Medical Technologies focuses on reducing these hidden costs to improve healthcare efficiency and enhance patient quality of life.
🩺 Complications
Every battery replacement surgery for medical implants carries significant risks, with 4% of procedures resulting in major complications, such as infections or the need for additional surgical interventions. Additionally, 7% of these surgeries lead to minor complications that adversely affect patients' daily lives and health. Kudu Medical Technologies is dedicated to addressing these serious concerns by advancing technologies that reduce these risks and enhance patient outcomes, thereby transforming post-surgical care in the medical device industry.

Poole, Jeanne E., et al. "Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry." Circulation 122.16 (2010): 1553-1561.‏
The Solution
Ultrasound Power Transfer
Kudu Medical Technologies is revolutionizing the field with our cutting-edge ultrasound technology, designed to power up any medical implant on the market in under an hour. Our innovative wireless charging system safely transmits ultrasound waves through the skin to a receiver embedded in the implant, converting these waves into electrical energy to recharge the device's battery. This breakthrough not only ensures universal compatibility with all current implant models but also supports the development of new implant technologies previously limited by battery life constraints.
Tailored Charging Modules
Our advanced modules are designed to seamlessly integrate with existing medical implants, fully replacing the old battery. They include ultrasound charging electronics, a flat ultrasound receiver, and a powerful rechargeable battery.
Universal Chargers
Our universal chargers are compatible with all Kudu charging modules, making the charging process simple and efficient. The chargers feature a transducer array and are AI-driven and cloud-operated for optimal performance.
Benefits of Ultrasound Power Transfer
Our revolutionary solution not only eliminates battery replacement surgeries for medical implants but also drastically reduces associated costs. Leveraging advanced ultrasound technology, our patent-protected wireless charging system extends the lifespan of devices and opens the door to new types of medical implants previously deemed impossible. This innovation significantly enhances patient safety and care while introducing new revenue streams for medical device manufacturers through our unique business model, transforming the landscape for implantable medical devices.
💉 Reducing Procedures
Our ultrasound-based charging system removes the necessity for frequent battery replacements, enhancing patient experience and reducing healthcare costs.
👨‍⚕️ Enhanced Safety and Comfort
Our approach drastically lowers the risk of infections related to surgical battery replacements, improves implant safety and longevity, and boosts patient well-being.
🗲 Super Fast Charge
Our proprietary hardware and algorithms enable a quick, safe, and efficient charging process using standard ultrasound transmitters. This technology provides ample power to support every implant on the market today without compromising safety or increasing complexity for implant manufacturers.
💸 New Revenue Streams
Our business model opens up new avenues for manufacturers, such as charging as a service, which not only adds value but also generates ongoing revenue after the implant is delivered to the patient.
Expert Endorsement
Dr. Michael Barkagan, MD, is a physician-scientist, a specialist in cardiac electrophysiology at Shamir Medical Center, and a Senior Clinical Lecturer at Tel Aviv University’s School of Medicine. He completed his postdoctoral fellowship at Harvard Medical School, where he focused on the mechanisms of arrhythmias and the development of innovative diagnostic and invasive treatment technologies. He brings extensive expertise in cardiac arrhythmias and cardiac electronic implantable device management, with clinical experience and advanced training at leading institutions, including Beth-Israel Deaconess Medical Center in Boston.
Dr. Michael Barkagan, has endorsed our groundbreaking ultrasound power transfer technology for medical implants. Dr. Barkagan highlights several benefits: substantial reductions in infection risks from surgical battery replacements, improved implant safety and longevity, decreased medical expenditures, and enhanced patient well-being.
Current Status
We’ve achieved key milestones in advancing our innovative ultrasound power transfer technology, with five pending patents (including four in PCT). Currently in the experimental validation stage, we are progressing towards FDA approval via the STEP pathway, supported by investment from the Israeli Innovation Authority. Our proprietary business model generates recurring revenue through charging stations, disposable probes, and subscription-based AI-powered charging profiles. We’re also building a robust reimbursement strategy to ensure market success. Actively seeking strategic partners, our technology aims to enhance patient safety, reduce healthcare costs, and enable groundbreaking innovations in medical devices, opening new possibilities for the future of healthcare.
The Team
Yuval Shklarsh
CEO \ CTO
Yuval Shklarsh, Founder and CEO of Kudu Medical Technologies, is a distinguished electrical engineer with a solid decade of industry experience. Educated at Technion - Israel Institute of Technology with multiple degrees, Yuval contributes extensive technical expertise and a knack for innovation to the company.
Dr. Michael Barkagan
Medical Advisor
Dr. Michael Barkagan, MD, is a cardiac electrophysiologist at Shamir Medical Center and a Senior Clinical Lecturer at Tel Aviv University’s School of Medicine. He completed a postdoctoral fellowship at Harvard Medical School, where he studied arrhythmia mechanisms and developed innovative treatment technologies. With expertise in cardiac arrhythmias and implantable devices, Dr. Barkagan has trained at leading institutions, including Beth Israel Deaconess Medical Center in Boston.
Dr. Andrew H. Locke
Medical Advisor
Dr. Andrew H. Locke, MD, is a cardiac electrophysiologist at the Harvard Thorndike Electrophysiology Institute at Beth Israel Deaconess Medical Center and an Instructor of Medicine at Harvard Medical School. He completed his medical degree at Tufts University School of Medicine and advanced training in cardiology and electrophysiology at Beth Israel Deaconess. Board-certified in Clinical Cardiac Electrophysiology, Dr. Locke specializes in the treatment of cardiac arrhythmias and innovative approaches to electrophysiology.
Advisory Board
Yossi Ben Harosh
Chairman
Yossi is a seasoned C-level executive with 25+ years of experience leading HighTech companies. His roles have included President & CEO of Telrad Networks, Division President at Amdocs, and CEO at both RiT Technologies and Cnoga Digital Care Ltd. With a robust background in sales, marketing, operations, and business development, Yossi has driven significant growth and turnarounds in his companies. He is also an active member of YPO.
Get in Touch
Kudu Medical Technologies is located in the heart of Tel Aviv, Israel. Our innovative team is dedicated to revolutionizing medical implant charging through our groundbreaking ultrasound technology.
For more information, please contact us at shklarsh.yuval@gmail.com or call us at +972 542515698.
Kudu Medical Technologies - Reducing Procedures, Enhancing Lives